About Adiana
Adiana is a Healthcare company based in Marlborough (United States) founded in 1997, and was acquired by Cytyc in February 2007. Transcervical sterilization systems for permanent birth control are developed. Adiana has raised $23 million across 1 funding round from investors including Boston Scientific, Orbimed and Abingworth. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its competitors include Daré Bioscience, Femasys and Hera Health Solutions; 2 of its 3 listed competitors have raised funding.
Company details
The company was founded in 1997 in Marlborough, United States, focusing on medical devices in womens health. A transcervical sterilization system for permanent birth control was developed, incorporating a radiofrequency generator, disposable delivery catheter, and implantable polymer matrix per fallopian tube. FDA approval was received in 2009. Acquisition by Cytyc, now part of Hologic, occurred in February 2007.
- Headquarters Marlborough, United States
- Stage Acquired
- SectorsHealthcare
- Website adiana.com
- Social X
- Acquired by Cytyc (Feb 2007)
- Total Equity Funding$23M (USD)
in 1 rounds
- Latest Funding Round$23M (USD), Series D
Aug 2005
- InvestorsBoston Scientific
& 9 more
- Acquired byCytyc
(Feb 2007)
Funding Insights of Adiana
Adiana has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series D round of $23 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23M
- Total Rounds 1
- Last Round Series D — $23M
- First Round $23M
(Aug 2005)
- Investors Count 9
All 1 funding rounds of Adiana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2005 | $23M | Series D | – | Tullis Health Investors |
10 investors in total: 10 institutional.
Investors in Adiana
Adiana has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Orbimed and Abingworth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare investments are made by Tullis Health Investors. | tullisfunds.com | Palm Beach Gardens, United States | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Early stage venture capital firm investing in the US | alloyventures.com | Palo Alto, United States | ||
Investments are made in life sciences firms across all stages. | delphiventures.com | Menlo Park, United States | ||
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Life Sciences focused VC firm that does early stage investments in the US | forwardventures.com | San Diego, United States | ||
Growth stage VC fund investing in the US, Europe and Canada | oakwoodmedical.com | St. Louis, United States | ||
Tech and Life Sciences focused corporate VC firm investing in the US | kpventures.com | Oakland, United States | ||
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States | |
Diagnostic medical devices for cancer and women's health are developed. | 1987 | cytyc.com | Marlborough, United States |
Investor details for Adiana
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Adiana
3 dated milestones of Adiana across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Adiana is founded.
- Funding First funding round of $23.0M.
- Exit Acquired by Cytyc.
Competitors of Adiana
Adiana has 3 listed competitors in our database, 2 of them funded. They include Daré Bioscience, Femasys and Hera Health Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| darebioscience.com | 2005 | San Diego, United States | 30 | Non-hormonal pharmaceutical products for female contraceptives are developed. | ||
| femasys.com | 2004 | Atlanta, United States | $69.22M | 25 | Medical devices for women's healthcare are developed and provided. | |
| herahealthsolutions.com | 2017 | Dallas, United States | $227,358 | Contraceptive arm implants are developed for female birth control. |
Detailed competitors of Adiana
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Adiana
Websites that share an audience with Adiana (adiana.com).
Websites whose visitors overlap most with Adiana. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
essure.com | essure.com | 100% | #5,771,977 | – |
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Adiana (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Adiana
Complete news archive for Adiana
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adiana
Adiana was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Adiana is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Adiana is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series D of $23M, raised on Aug 2005.
The company was founded in 1997 in Marlborough, United States, focusing on medical devices in womens health. A transcervical sterilization system for permanent birth control was developed, incorporating a radiofrequency generator, disposable delivery catheter, and implantable polymer matrix per fallopian tube. FDA approval was received in 2009. Acquisition by Cytyc, now part of Hologic, occurred in February 2007.
Adiana's top competitors include Daré Bioscience, Femasys and Hera Health Solutions.
Adiana has 10 investors. Key investors include Boston Scientific, Orbimed, Abingworth, Cytyc, and Tullis Health Investors.
Yes. Adiana was acquired by Cytyc in February 2007.

